|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 436.27 USD | -2.35% |
|
-0.56% | -3.77% |
| Capitalization | 111B 94.53B 87.49B 82.38B 153B 10,321B 157B 1,026B 402B 4,956B 416B 408B 17,659B | P/E ratio 2026 * |
24.9x | P/E ratio 2027 * | 21.7x |
|---|---|---|---|---|---|
| Enterprise value | 97.88B 83.39B 77.17B 72.66B 135B 9,104B 138B 905B 354B 4,372B 367B 360B 15,576B | EV / Sales 2026 * |
7.51x | EV / Sales 2027 * | 6.52x |
| Free-Float |
99.04% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -2.35% | ||
| 1 week | -0.56% | ||
| Current month | -2.30% | ||
| 1 month | -12.60% | ||
| 3 months | -5.95% | ||
| 6 months | +6.98% | ||
| Current year | -3.77% |
| 1 week | 425.26 |  | 447 |
| 1 month | 425.26 | | 489.97 |
| Current year | 425.26 | | 507.92 |
| 1 year | 362.5 | | 510.77 |
| 3 years | 316.43 | | 519.88 |
| 5 years | 176.36 | | 519.88 |
| 10 years | 71.46 | | 519.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 58 | 10/04/2019 |
Mark Bunnage
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.35% | -0.56% | -8.25% | +34.97% | 111B | |
| -1.65% | +0.42% | +30.32% | +155.99% | 841B | |
| -1.18% | -1.88% | +60.37% | +45.12% | 574B | |
| -2.10% | -0.43% | +19.37% | +28.93% | 368B | |
| -0.09% | 0.00% | +30.86% | +15.85% | 320B | |
| -0.30% | -0.56% | +52.03% | +30.17% | 318B | |
| -1.03% | +0.46% | +56.57% | +7.82% | 300B | |
| -0.34% | -1.17% | +43.74% | +39.79% | 295B | |
| -1.29% | +0.89% | +24.74% | +39.90% | 189B | |
| -2.18% | -0.52% | +37.07% | +68.27% | 173B | |
| Average | -0.87% | +0.19% | +34.68% | +46.68% | 348.88B | |
| Weighted average by Cap. | -0.69% | -0.02% | +38.34% | +62.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.03B 11.1B 10.27B 9.67B 18.01B 1,212B 18.38B 120B 47.15B 582B 48.89B 47.86B 2,073B | 14.34B 12.22B 11.31B 10.65B 19.83B 1,334B 20.24B 133B 51.91B 641B 53.83B 52.68B 2,282B |
| Net income | 4.49B 3.82B 3.54B 3.33B 6.21B 418B 6.34B 41.52B 16.25B 201B 16.85B 16.49B 714B | 5.17B 4.4B 4.08B 3.84B 7.15B 481B 7.29B 47.82B 18.71B 231B 19.4B 18.99B 823B |
| Net Debt | -13.09B -11.15B -10.32B -9.72B -18.1B -1,217B -18.47B -121B -47.36B -585B -49.11B -48.07B -2,083B | -17.46B -14.88B -13.77B -12.96B -24.14B -1,624B -24.64B -162B -63.19B -780B -65.53B -64.14B -2,779B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/04/26 | 436.27 $ | -2.35% | 985,779 |
| 09/04/26 | 446.78 $ | +0.64% | 1,040,964 |
| 08/04/26 | 443.92 $ | +2.79% | 1,279,267 |
| 07/04/26 | 431.86 $ | -0.56% | 1,029,161 |
| 06/04/26 | 434.30 $ | -1.01% | 948,862 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition